Description
Impressive response to eribulin in endocrine- and chemotherapy-resistant metastatic breast cancer
Article: Impressive response to eribulin in endocrine- and chemotherapy-resistant metastatic breast cancer
€3.03
€3.03
Impressive response to eribulin in endocrine- and chemotherapy-resistant metastatic breast cancer
Top